Influence of polyethylene glycol coating on biodistribution and toxicity of nanoscale graphene oxide in mice after intravenous injection

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 4697-4707

  Li, B ^a,b   Zhang, Xiao Yong ^a   Yang, Jian Zhong ^a   Zhang, Yu Jie ^a   Li, Wen Xin ^a   Fan, Chun Hai ^a   Huang, Qing ^a  

^a SHANGHAI INSTITUTE OF APPLIED PHYSICS   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Biodistribution; Graphene oxide; Polyethylene glycol; Toxicity

Indexed keywords

GRAPHENE OXIDE; MACROGOL; NANOMATERIAL; NANOSCALE GRAPHENE OXIDE; UNCLASSIFIED DRUG; BIOMATERIAL; GRAPHITE; MACROGOL DERIVATIVE; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODISTRIBUTION; CHEMICAL PARAMETERS; CLEARANCE; CONTROLLED STUDY; KIDNEY INJURY; LIVER FIBROSIS; LIVER INJURY; LUNG FIBROSIS; LUNG INJURY; MALE; MATERIAL COATING; MOUSE; NONHUMAN; TISSUE DISTRIBUTION; TISSUE INJURY; TOXICITY; WEIGHT REDUCTION; ANIMAL; BODY WEIGHT; CHEMISTRY; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LUNG; PATHOLOGY;

MUS;

ANIMALS; BODY WEIGHT; COATED MATERIALS, BIOCOMPATIBLE; GRAPHITE; INJECTIONS, INTRAVENOUS; LIVER; LUNG; MALE; MICE; NANOPARTICLES; POLYETHYLENE GLYCOLS; TISSUE DISTRIBUTION;

EID: 84907874124     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S66591     Document Type: Article

References (30)

1. Shan CS, Yang HF, Han DX, Zhang QX, Ivaska A, Niu L. Water-soluble graphene covalently functionalized by biocompatible poly-L-lysine. Langmuir. 2009;25:12030-12033.
2. Xiao LQ, Liao LQ, Liu LJ. Chemical modification of graphene oxide with carbethoxycarbene under microwave irradiation. Chem Phys Lett. 2013;556:376-379.
3. Wu CK, Wang GJ, Dai JF. Controlled functionalization of graphene oxide through surface modification with acetone. J Mater Sci. 2013;48:3436-3442.
4. Bustos-Ramirez K, Martinez-Hernandez AL, Martinez-Barrera G, de Icaza M, Castano VM, Velasco-Santos C. Covalently bonded chitosan on graphene oxide via redox reaction. Materials. 2013;6(3):911-926.
5. Bai YC, Rakhi RB, Chen W, Alshareef HN. Effect of pH-induced chemical modification of hydrothermally reduced graphene oxide on supercapacitor performance. J Power Sources. 2013;233:313-319.
6. Liu Z., Feng LZ. Graphene in biomedicine: opportunities and challenges. Nanomedicine. 2011;6:317-324.
7. Kavitha T, Kang IK, Park SY. Poly(acrylic acid)-grafted graphene oxide as an intracellular protein carrier. Langmuir. 2014;30:402-409.
8. Wu SL, Zhao XD, Cui ZG, et al. Cytotoxicity of graphene oxide and graphene oxide loaded with doxorubicin on human multiple myeloma cells. Int J Nanomedicine. 2014;9:1413-1421.
9. Tu Q, Pang L, Chen Y, et al. Effects of surface charges of graphene oxide on neuronal outgrowth and branching. Analyst. 2014;139:105-115.
10. Zhang M, Le HN, Ye BC. Graphene oxide-based fluorescent “on/off” switch for visual bioassay using “molecular beacon”-hosted Hoechst dyes. ACS Appl Mater Interface. 2013;5:8278-8282.
11. Wang H, Gu W, Xiao N, Ye L, Xu QY. Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug. Int J Nanomedicine. 2014;9:1433-1442.
12. Wang HX, Sun DM, Zhao NN, et al. Thermo-sensitive graphene oxide-polymer nanoparticle hybrids: synthesis, characterization, biocompatibility and drug delivery. J Mater Chem B. 2014;2:1362-1370.
13. Lim DJ, Sim M, Oh L, Lim K, Park H. Carbon-based drug delivery carriers for cancer therapy. Arch Pharm Res. 2014;37:43-52.
14. Ernsting MJ, Tang WL, MacCallum NW, Li SD. Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models. Biomaterials. 2012;33:1445-1454.
15. Bao YJ, Jin Y, Chivukula P, et al. Effect of PEGylation on biodistribution and gene silencing of siRNA/lipid nanoparticle complexes. Pharm Res. 2013;30:342-351.
16. Shah NB, Vercellotti GM, White JG, Fegan A, Wagner CR, Bischof JC. Blood-nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties. Mol Pharm. 2012;9:2146-2155.
17. Lu F, Doane TL, Zhu JJ, Burda C. A method for separating PEGylated Au nanoparticle ensembles as a function of grafting density and core size. Chem Commun. 2014;50:642-644.
18. Tobin LA, Xie YL, Tsokos M, et al. Pegylated siRNA-loaded calcium phosphate nanoparticle-driven amplification of cancer cell internalization in vivo. Biomaterials. 2013;34:2980-2990.
19. Lak A, Dieckhoff J, Ludwig F, et al. Highly stable monodisperse PEGylated iron oxide nanoparticle aqueous suspensions: a nontoxic tracer for homogeneous magnetic bioassays. Nanoscale. 2013;5:11447-11455.
20. Chaudhari KR, Ukawala M, Manjappa AS, et al. Opsonization, biodistribution, cellular uptake and apoptosis study of PEGylated PBCA nanoparticle as potential drug delivery carrier. Pharm Res. 2012;29:53-68.
21. Ernsting MJ, Murakami M, Roy A, Li SD. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Control Release. 2013;172:782-794.
22. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2012;64:206-212.
23. Yang K, Zhang S, Zhang G, Sun X, Lee ST, Liu Z. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 2010;10:3318-3323.
24. Li B, Yang JZ, Huang Q, et al. Biodistribution and pulmonary toxicity of intratracheally instilled graphene oxide in mice. NPG Asia Materials. 2013;5.
25. Duan XP, Li YP. Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. Small. 2013;9:1521-1532.
26. In I, Park YJ, Park SY. Preparation of water soluble graphene using polyethylene glycol: comparison of covalent approach and noncovalent approach. Journal of Industrial and Engineering Chemistry. 2011;17:298-303.
27. Prantner AM, Scholler N. Biological barriers and current strategies for modifying nanoparticle bioavailability. J Nanosci Nanotechnol. 2014;14:115-125.
28. Jones SW, Roberts RA, Robbins GR, et al. Nanoparticle clearance is governed by Th1/Th2 immunity and strain background. J Clin Invest. 2013;123:3061-3073.
29. Zhang XY, Yin JL, Peng C, et al. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. Carbon. 2011;49:986-995.
30. Yang K, Wan J, Zhang S, Zhang Y, Lee ST, Liu Z. In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano. 2011;5:516-522.